SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-063389
Filing Date
2021-03-01
Accepted
2021-03-01 16:02:06
Documents
4
Period of Report
2021-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d143780d6k.htm 6-K 15622
2 EX-99.1 d143780dex991.htm EX-99.1 11276
3 EX-99.2 d143780dex992.htm EX-99.2 317647
4 GRAPHIC g143780g0301131749865.jpg GRAPHIC 21775
  Complete submission text file 0001193125-21-063389.txt   375722
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 21697619
SIC: 2834 Pharmaceutical Preparations